Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
132
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Report

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers

Sungpil Han1 Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-4674-7682
ORCID Icon,
Yo Han Kim1 Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Hee Youn Choi1 Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Dong-Jun Soh2 Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
,
Jeongmin Kim2 Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
,
Joonwoo Nam2 Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
,
Jong-Woo Kim2 Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
,
Kyun-Seop Bae1 Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
&
Hyeong-Seok Lim1 Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
 show all
Pages 3189-3199 | Published online: 05 Aug 2020

References

  • JauchEC, SaverJL, AdamsHP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(3):870–947. doi:10.1161/STR.0b013e318284056a23370205
  • KernanWN, OvbiageleB, BlackHR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2014;45(7):2160–2236. doi:10.1161/STR.000000000000002424788967
  • LansbergMG, O’DonnellMJ, KhatriP, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e601S–e636S. doi:10.1378/chest.11-230222315273
  • National Institute of Neurological D. Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–1587. doi:10.1056/NEJM1995121433324017477192
  • MyslimiF, CaparrosF, Dequatre-PonchelleN, et al. Orolingual angioedema during or after thrombolysis for cerebral ischemia. Stroke. 2016;47(7):1825–1830. doi:10.1161/STROKEAHA.116.01333427197851
  • MoroniF, ChiarugiA. Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment. FEBS J. 2009;276(1):36–45. doi:10.1111/j.1742-4658.2008.06768.x19087198
  • KauppinenTM. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease. Neurochem Int. 2007;50(7–8):954–958. doi:10.1016/j.neuint.2006.11.01017222947
  • StoicaBA, LoaneDJ, ZhaoZ, et al. PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury. J Neurotrauma. 2014;31(8):758–772. doi:10.1089/neu.2013.319424476502
  • RomS, Zuluaga-RamirezV, DykstraH, ReichenbachNL, RamirezSH, PersidskyY. Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions. J Cereb Blood Flow Metab. 2015;35(1):28–36. doi:10.1038/jcbfm.2014.16725248836
  • MatsuuraS, EgiY, YukiS, HorikawaT, SatohH, AkiraT. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model. Brain Res. 2011;1410:122–131. doi:10.1016/j.brainres.2011.05.06921741620
  • KimY, KimYS, NohMY, et al. Neuroprotective effects of a novel poly (ADP-ribose) polymerase-1 inhibitor, JPI-289, in hypoxic rat cortical neurons. Clin Exp Pharmacol Physiol. 2017;44(6):671–679.28370165
  • ShimizuT, MaceyTA, QuillinanN, et al. Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury. J Cereb Blood Flow Metab. 2013;33(10):1549–1555. doi:10.1038/jcbfm.2013.10523801245
  • FordAL, LeeJM. Climbing STAIRs towards clinical trials with a novel PARP-1 inhibitor for the treatment of ischemic stroke. Brain Res. 2011;1410:120–121. doi:10.1016/j.brainres.2011.07.00121807360
  • KimY, KimYS, KimHY, et al. Early treatment with poly(ADP-Ribose) polymerase-1 Inhibitor (JPI-289) reduces infarct volume and improves long-term behavior in an animal model of ischemic stroke. Mol Neurobiol. 2018;55(9):7153–7163. doi:10.1007/s12035-018-0910-629383691
  • NohMY, LeeWM, LeeSJ, KimHY, KimSH, KimYS. Regulatory T cells increase after treatment with poly (ADP-ribose) polymerase-1 inhibitor in ischemic stroke patients. Int Immunopharmacol. 2018;60:104–110. doi:10.1016/j.intimp.2018.04.04329709770
  • U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, MD: USFDA; 2005.
  • LinKY, KrausWL. PARP inhibitors for cancer therapy. Cell. 2017;169(2):183. doi:10.1016/j.cell.2017.03.03428388401
  • ChanEM, ShibueT, McFarlandJM, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. 2019;568(7753):551–556. doi:10.1038/s41586-019-1102-x30971823
  • TuliR, ShiaoSL, NissenN, et al. A Phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer. EBioMedicine. 2019;40:375–381. doi:10.1016/j.ebiom.2018.12.06030635165

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.